Commonwealth Equity Services’s Twist Bioscience TWST Stock Holding History

Commonwealth Equity Services’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-6,193	Closed	-$305K	–	3802
2022 Q1	$305K	Buy	6,193 +2,015	+48%	+$112K	﹤0.01%	2961
2021 Q4	$323K	Sell	4,178 -190	-4%	-$19.5K	﹤0.01%	2905
2021 Q3	$467K	Buy	4,368 +137	+3%	+$15.7K	﹤0.01%	2523
2021 Q2	$563K	Buy	4,231 +99	+2%	+$11.5K	﹤0.01%	2371
2021 Q1	$511K	Buy	4,132 +133	+3%	+$20.2K	﹤0.01%	2319
2020 Q4	$565K	Buy	3,999 +158	+4%	+$17.5K	﹤0.01%	2069
2020 Q3	$291K	Buy	+3,841	New	+$239K	﹤0.01%	2381

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Commonwealth Equity Services's TWST Position: Q2 2022 in Review

Commonwealth Equity Services sold out of Twist Bioscience (TWST) in Q2 2022, closing a stake of 6,193 shares — an estimated $305K sold.

Commonwealth Equity Services first reported a position in TWST in Q3 2020 and held it in 7 quarters. The position peaked at $565K in Q4 2020. 204 funds tracked by Wall St. Rank hold TWST as of Q2 2022.

Commonwealth Equity Services reported no remaining Twist Bioscience position as of Q2 2022 after selling out during the quarter.
Commonwealth Equity Services sold 6,193 Twist Bioscience shares in Q2 2022, an estimated $305K.
Commonwealth Equity Services first reported a position in Twist Bioscience in Q3 2020 and held it in 7 quarters.
Commonwealth Equity Services's Twist Bioscience position peaked at $565K in Q4 2020.
204 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2022.

Based on Commonwealth Equity Services's 13F filing for Q2 2022, filed 19 Jul 2022.